The use of chemicals is essential in our production of active
pharmaceutical ingredients (API). We strive to avoid the use of
hazardous chemicals, and most of the chemicals we use are
The use of chemicals that can be hazardous to humans or the
environment is strictly regulated and they will always be handled with
high caution. Finding non-hazardous alternatives and supporting the
use of safe chemicals are two of our top priorities.
We work in compliance with present legislation and monitor future
legislation very closely. All our manufacturing sites comply with
local environmental regulation, and we continuously follow new
developments to implement new regulations in due time. We are
currently focusing on the EU REACH regulation, which urges industry to
phase out certain hazardous substances.
We work to substitute harmful substances. Within Research & Development (R&D) we are continuously working to ensure that hazardous substances are substituted. Though often a challenging task, we have already managed to substitute several substances from our pipeline, and today we only use a few substances of very high concern in our production.
We engage with our stakeholders to address environmental concerns.
We are part of the industry-wide cooperation Pharmaceuticals in the
Environment (PiE), just as we work closely with The European
Federation of Pharmaceutical Industries and Associations (EFPIA) to
address the potential environmental impact of pharmaceuticals.
We collect waste streams containing chemicals of very high concern,
and they are treated by an approved third party vendor. Thereby we
ensure that such substances are not discharged into the nature.
More details can be found in the Novo Nordisk Annual Report 2017.